Back to Search
Start Over
Plasma coenzyme Q10 status is impaired in selected genetic conditions
- Source :
- Digital.CSIC. Repositorio Institucional del CSIC, instname, Zaguán. Repositorio Digital de la Universidad de Zaragoza, SCIENTIFIC REPORTS, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu, Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019), r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
- Publication Year :
- 2019
- Publisher :
- Springer Nature, 2019.
-
Abstract
- © The Author(s) 2019.<br />Identifying diseases displaying chronic low plasma Coenzyme Q10 (CoQ) values may be important to prevent possible cardiovascular dysfunction. The aim of this study was to retrospectively evaluate plasma CoQ concentrations in a large cohort of pediatric and young adult patients. We evaluated plasma CoQ values in 597 individuals (age range 1 month to 43 years, average 11 years), studied during the period 2005–2016. Patients were classified into 6 different groups: control group of healthy participants, phenylketonuric patients (PKU), patients with mucopolysaccharidoses (MPS), patients with other inborn errors of metabolism (IEM), patients with neurogenetic diseases, and individuals with neurological diseases with no genetic diagnosis. Plasma total CoQ was measured by reverse-phase high-performance liquid chromatography with electrochemical detection and ultraviolet detection at 275 nm. ANOVA with Bonferroni correction showed that plasma CoQ values were significantly lower in the PKU and MPS groups than in controls and neurological patients. The IEM group showed intermediate values that were not significantly different from those of the controls. In PKU patients, the Chi-Square test showed a significant association between having low plasma CoQ values and being classic PKU patients. The percentage of neurogenetic and other neurological patients with low CoQ values was low (below 8%). In conclusión, plasma CoQ monitoring in selected groups of patients with different IEM (especially in PKU and MPS patients, but also in IEM under protein-restricted diets) seems advisable to prevent the possibility of a chronic blood CoQ suboptimal status in such groups of patients.<br />This work was supported by grant from the Instituto de Salud Carlos III (ISCIII-FIS PI17/00109, PI17/00021, PI17/01286, PI15/00166 and PI15/01082), the FEDER Funding Program from the European Union, CIBERER-ISCIII and Departamento de Ciencia, Tecnología y Universidad del Gobierno de Aragón (Grupos de Referencia B33_17R).
- Subjects :
- 0301 basic medicine
RM
congenital, hereditary, and neonatal diseases and abnormalities
medicine.medical_specialty
Neurology
lcsh:Medicine
Electrochemical detection
Gastroenterology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Internal medicine
medicine
Young adult
lcsh:Science
Coenzyme Q10
Multidisciplinary
business.industry
lcsh:R
nutritional and metabolic diseases
food and beverages
Large cohort
030104 developmental biology
chemistry
lcsh:Q
Analysis of variance
Genetic diagnosis
business
030217 neurology & neurosurgery
Biomarkers
Subjects
Details
- ISSN :
- 20452322
- Database :
- OpenAIRE
- Journal :
- Digital.CSIC. Repositorio Institucional del CSIC, instname, Zaguán. Repositorio Digital de la Universidad de Zaragoza, SCIENTIFIC REPORTS, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu, Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019), r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
- Accession number :
- edsair.doi.dedup.....b5a92c9f23561021c0ff49c6fc5d8c12